Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
PROGENICS PHARMACEUTICALS INC (PGNX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/23/2020 4 Das Asha (Chief Medical Officer) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 125,000 options to buy @ $4.56, valued at $570k
Disposed/sold 82,214 options to buy @ $4.77, valued at $392.2k
06/23/2020 4 Osorio Benedict (COO) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 21,202 shares @ $0
Disposed/sold 100,000 options to buy @ $6.62, valued at $662k
Disposed/sold 90,750 options to buy @ $4.52, valued at $410.2k
Disposed/sold 82,214 options to buy @ $4.77, valued at $392.2k
06/23/2020 4 Tenbarge Bryce (SVP, Commercial) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 75,000 options to buy @ $6.77, valued at $507.8k
Disposed/sold 66,000 options to buy @ $11.32, valued at $747.1k
Disposed/sold 75,900 options to buy @ $6.62, valued at $502.5k
Disposed/sold 90,750 options to buy @ $4.52, valued at $410.2k
Disposed/sold 82,214 options to buy @ $4.77, valued at $392.2k
06/23/2020 4 Wong Vivien (EVP, Development) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 4,121 shares @ $0
Disposed/sold 6,000 options to buy @ $5.35, valued at $32.1k
Disposed/sold 25,000 options to buy @ $4.83, valued at $120.8k
Disposed/sold 60,000 options to buy @ $7.4, valued at $444k
Disposed/sold 40,000 options to buy @ $9.81, valued at $392.4k
Disposed/sold 48,000 options to buy @ $5.03, valued at $241.4k
Disposed/sold 52,800 options to buy @ $4.7, valued at $248.2k
Disposed/sold 75,000 options to buy @ $4.7, valued at $352.5k
Disposed/sold 66,000 options to buy @ $6.65, valued at $438.9k
Disposed/sold 82,500 options to buy @ $4.52, valued at $372.9k
Disposed/sold 82,500 options to buy @ $11.32, valued at $933.9k
06/23/2020 4 Mims David W. (Interim CEO and Interim CFO) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 40,000 options to buy @ $5.01, valued at $200.4k
Disposed/sold 16,393 options to buy @ $5.01, valued at $82.1k
06/23/2020 4 Ber Gerard (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 50,000 shares @ $0
Disposed/sold 40,000 options to buy @ $5.01, valued at $200.4k
Disposed/sold 16,393 options to buy @ $5.01, valued at $82.1k
06/23/2020 4 Campbell Bradley L (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 12,000 shares @ $0
Disposed/sold 28,000 options to buy @ $4.89, valued at $136.9k
Disposed/sold 20,000 options to buy @ $6.95, valued at $139k
Disposed/sold 25,000 options to buy @ $8.99, valued at $224.8k
Disposed/sold 25,000 options to buy @ $5.74, valued at $143.5k
06/23/2020 4 Ende Eric J (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 40,000 options to buy @ $5.01, valued at $200.4k
Disposed/sold 16,393 options to buy @ $5.01, valued at $82.1k
06/23/2020 4 Ferrante Karen Jean (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 40,000 options to buy @ $4.5, valued at $180k
Disposed/sold 20,000 options to buy @ $4.47, valued at $89.4k
Disposed/sold 20,000 options to buy @ $6.72, valued at $134.4k
Disposed/sold 20,000 options to buy @ $4.89, valued at $97.8k
Disposed/sold 20,000 options to buy @ $6.95, valued at $139k
Disposed/sold 25,000 options to buy @ $8.99, valued at $224.8k
Disposed/sold 25,000 options to buy @ $5.74, valued at $143.5k
06/23/2020 4 MacDougall Ann L. (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 40,000 options to buy @ $5.01, valued at $200.4k
Disposed/sold 36,065 options to buy @ $5.01, valued at $180.7k
06/23/2020 4 Maeusli Heinz Christoph (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Disposed/sold 40,000 options to buy @ $5.01, valued at $200.4k
Disposed/sold 16,393 options to buy @ $5.01, valued at $82.1k
03/04/2020 4 Das Asha (Chief Medical Officer) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 82,214 options to buy @ $4.77, valued at $392.2k
03/04/2020 4 Osorio Benedict (COO) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 82,214 options to buy @ $4.77, valued at $392.2k
03/04/2020 4 Wong Vivien (EVP, Development) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 82,214 options to buy @ $4.77, valued at $392.2k
03/04/2020 4 Tenbarge Bryce (SVP, Commercial) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 82,214 options to buy @ $4.77, valued at $392.2k
03/04/2020 4 Fabbio Patrick (CFO) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 82,214 options to buy @ $4.77, valued at $392.2k
12/17/2019 4 Maeusli Heinz Christoph (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 16,393 options to buy @ $5.01, valued at $82.1k
12/17/2019 4 Maeusli Heinz Christoph (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 40,000 options to buy @ $5.01, valued at $200.4k
12/17/2019 4 Mims David W. (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 16,393 options to buy @ $5.01, valued at $82.1k
12/17/2019 4 Mims David W. (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 40,000 options to buy @ $5.01, valued at $200.4k
12/17/2019 4 MacDougall Ann L. (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 36,065 options to buy @ $5.01, valued at $180.7k
12/17/2019 4 MacDougall Ann L. (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 40,000 options to buy @ $5.01, valued at $200.4k
12/17/2019 4 Ende Eric J (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 16,393 options to buy @ $5.01, valued at $82.1k
12/17/2019 4 Ende Eric J (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 40,000 options to buy @ $5.01, valued at $200.4k
12/17/2019 4 Ber Gerard (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 16,393 options to buy @ $5.01, valued at $82.1k
12/17/2019 4 Ber Gerard (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Granted 40,000 options to buy @ $5.01, valued at $200.4k
09/27/2019 3 MacDougall Ann L. (10% Owner) has filed a Form 3 on PROGENICS PHARMACEUTICALS INC
09/27/2019 3 Mims David W. (10% Owner) has filed a Form 3 on PROGENICS PHARMACEUTICALS INC
09/27/2019 3 Maeusli Heinz Christoph (10% Owner) has filed a Form 3 on PROGENICS PHARMACEUTICALS INC
09/27/2019 3 Ende Eric J (10% Owner) has filed a Form 3 on PROGENICS PHARMACEUTICALS INC
09/27/2019 3 Ber Gerard (10% Owner) has filed a Form 3 on PROGENICS PHARMACEUTICALS INC
09/11/2019 4 Velan Capital, L.P. (10% Owner) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Bought 72,023 shares @ $4.9947, valued at $359.7k
09/09/2019 4 LTE Partners, LLC (10% Owner) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Bought 43,520 shares @ $4.6208, valued at $201.1k
Bought 21,480 shares @ $4.9393, valued at $106.1k
09/05/2019 4 Velan Capital, L.P. (10% Owner) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC
Txns: Bought 277,424 shares @ $4.3937, valued at $1.2M
Bought 243,614 shares @ $4.5093, valued at $1.1M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy